Catalyst Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
6/10
|
26.41 | 57.21 | -53.84% | 17.5 | +50.89% |
| P/S |
|
4.74 | 33.44 | -85.83% |
|
|
| P/BV |
|
4.86 | 4.65 | 4.62% |
|
|
| P/FCF |
|
-26.22 | 42.56 | -161.6% |
|
|
| Ev/Ebitda |
|
14.61 | -17.68 | -182.63% |
|
|
| Ev/S |
|
4.4 | 22.52 | -80.46% |
|
|
| Ev/FCF |
|
-31.9 | 47.58 | -167.03% |
|
|
| E/P |
|
0.0496 | 0.0188 | 163.79% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
9/10
|
30.12 | -13.3 | -326.5% | 36.04 | -16.41% |
| ROE |
|
18.41 | 9.69 | 89.99% |
|
|
| ROA |
|
15.13 | 0.2896 | 5125.14% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
17.93 | -25.08 | -171.5% |
|
|
| ROCE |
|
22.38 | 14.58 | 53.55% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.0297 | -3.62 | -100.82% | 0.0402 | -26.29% |
| Nеt Debt/Ebitda |
|
-1.12 | -4.05 | -72.41% |
|
|
| Debt/Ratio |
|
0.0075 | 0.1841 | -95.91% |
|
|
| Debt/Equity |
|
4.2 | 1.6 | 163.1% |
|
|
| Debt/Net Income |
|
0.0498 | 0.9168 | -94.57% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5448 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2387 | -100% |
|
|
| Average dividend growth |
|
0 | 1.55 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4954 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.64 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5448 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
289.23 | 31.71 | 812.11% | ||
| Growth impulse Ebitda in 5 years |
|
276.12 | -23.28 | -1286.08% | ||
| Growth impulse Net Income in 5 years |
|
124.03 | -61.56 | -301.48% | ||
| Growth impulse FCF in 5 years |
|
-258.78 | -26 | 895.31% | ||
| Growth impulse EPS in 5 years |
|
108.8 | -63.63 | -270.99% |
IP Score
5.55/10
